Back to CBIO
Vestal Point Capital, LP → CBIO
Vestal Point Capital, LP CBIO Position History
Crescent Biopharma, Inc. • Healthcare
Quarters held
4
Latest value
$43.8M
Q3 2026
Peak value
$43.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $17.8M |
| Q1 2026 | $27.6M |
| Q2 2026 | $29.3M |
| Q3 2026 | $43.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $43.8M | 3.00M | — | — |
| Q2 2026 | $29.3M | 1.63M | — | — |
| Q1 2026 | $27.6M | 1.50M | — | — |
| Q4 2025 | $17.8M | 1.50M | — | — |
Other funds holding CBIO
$50.5M
$49.5M
$45.1M
$39.2M
$38.4M